Our Services

Our Brands

REPROCELL News

Prof Stefan Przyborski Giving Keynote Address at this year’s SMi 3D Cell Culture Conference
19-20 February 2020, Copthorne Tara, London, United Kingdom
REPROCELL Europe’s CSO Professor Stefan Przyborski will giving the keynote address on 3D cell culture at this year’s SMi 4th Annual Conference London, UK. There Prof Przyborski will also be showcasing REPROCELL’s range of Alvetex products for 3D cell culture. 

Patients with IBD absorb drugs differently from healthy individuals
16 January 2020
A recent study by researchers from REPROCELL found that IBD patients display different drug absorption profiles to healthy individuals. This is the first time that drug absorption has been estimated using inflamed GI tissue from this patient group.

REPROCELL can now predict oral bioavailability in fresh IBD tissue
14 January 2020
Glasgow, UK: REPROCELL (Biopta) today announced that they can predict test article permeability using gastrointestinal (GI) resections from Inflammatory Bowel Disease (IBD) donors. This service, which is first of its kind to market, will allow ADME/DMPK scientists to estimate compound permeability in living human IBD tissue.

Early understanding of pharmacology and genomics can improve precision medicine strategies
23 December 2019
Glasgow, UK: REPROCELL (Biopta) today announced the successful publication of a novel study in  pharmacology and genomics to improve strategies for the development of precision medicines. The study – performed in collaboration with the NHS, academia and Scottish companies Fios Genomics, Systemic, and Aridhia – used human living lung tissue from Chronic Obstructive Pulmonary Disease (COPD) donors to explain inter-patient variation in drug efficacy.


See more REPROCELL Company News »


AACR Annual Meeting 2020
24-29 April 2020 / San Diego, CA, USA
REPROCELL/BioServe will join 20,000 cancer scientists from around the world. REPROCELL's Terri Lehman, Duncan Liew, and Rachna Goyal will be in attendance. Visit us at our Booth 3553.

BIO International Convention
8-11 June 2020 / San Diego, CA, USA
REPROCELL will join 17,000 life science and pharma leaders for a week of technical discussions, partnering, and networking. Visit us at the Scottish Pavilion Booth.

ISSCR Annual Meeting 2020
24-27 June 2020 / Boston, MA, USA
REPROCELL will be at the largest stem cell meeting in the world. Stop by our Booth 914 and meet REPROCELL team to learn about our CRISPR-SNIPER Technology and clinical-grade iPSC services.


See REPROCELL Upcoming Events »

REPROCELL Blog

Cost Effective, Lab-scale Spheroid Culture of iPSCs
21 January 2019
New small scale bioreactors for culturing iPSC spheroids fill the niche between standard culture plasticware and large scale options.

4 TED Talks discussing the future of regenerative medicine
19 December 2019
Planning ICC projects can be challenging as it requires careful selection of compatible antibodies, fluorochromes and blocking reagents.

How to Characterize Stem Cells using Immunocytochemistry
2 December 2019
Planning ICC projects can be challenging as it requires careful selection of compatible antibodies, fluorochromes and blocking reagents.

How SynFire® Technology can benefit your research
26 November 2019
In celebration of our distributorship with NeuCyte, REPROCELL catches up with NeuCyte’s Head of Neuroscience, Dr Daniel Haag, to discuss the benefits of SynFire technology.

Stem cells offer hope for sufferers of Spinocerebellar Ataxia
8 November 2019
Spinocerebellar ataxias (SCAs) are a group of inherited, genetically heterogeneous disorders which are characterised by ocular motor abnormalities, cognitive dysfunction, peripheral neuropathy and progressive cerebellar ataxia.

How to mass culture iPSCs in suspension
30 October 2019
In order to fully realize the potential of iPSCs for many of the above applications, there is a requirement to generate a vast number of cells; hence, an effective method of mass culture of iPSCs is highly sought after by iPSC researchers.

Improve your gene-editing success with CRISPR-SNIPER technology
29 October 2019
The discovery of both CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated proteins, the Cas nucleases, has revolutionized the field of gene-editing.


See more on the REPROCELL Blog »

Our Popular Products

Top